课题基金 / 基金详情

MK 0966 FOR TREATMENT OF MILD COGNITIVE IMPAIR & PREVENT OF CONVERSIO

MK 0966 FOR TREATMENT OF MILD COGNITIVE IMPAIR & PREVENT OF CONVERSIO
MK 0966 用于治疗轻度认知障碍
批准号：
6265088
负责人：
KAREN BELL
金额：
$0.04万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265088
关键词：
Alzheimer's disease clinical research cognition disorders drug /agent drug screening /evaluation human old age (65+) human subject human therapy evaluation mental disorder chemotherapy mental disorder prevention placebos

项目摘要

项目成果

KAREN BELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a two year placebo-controlled, parallel-groups, double-blind, multicenter study (with in-house blinding), to evaluate the effects of MK-0966 25mg on the prevention of Alzheimer's disease and cognitive decline in approximately 1300 patients > and = to 65 years of age with Mild Cognitive Impairment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN
HOMOCYSTEINE IN ALZHEIMER'S DISEASE
PREVENTION INSTRUMENT PROTOCOL
SIMVASTATIN AND ALZHEIMER'S DISEASE
海外基金